vs
Side-by-side financial comparison of BayCom Corp (BCML) and TriSalus Life Sciences, Inc. (TLSI). Click either name above to swap in a different company.
BayCom Corp is the larger business by last-quarter revenue ($25.9M vs $13.2M, roughly 2.0× TriSalus Life Sciences, Inc.). BayCom Corp runs the higher net margin — 26.5% vs -73.9%, a 100.3% gap on every dollar of revenue. On growth, TriSalus Life Sciences, Inc. posted the faster year-over-year revenue change (59.8% vs 9.4%). BayCom Corp produced more free cash flow last quarter ($30.1M vs $-2.5M). Over the past eight quarters, TriSalus Life Sciences, Inc.'s revenue compounded faster (43.0% CAGR vs 2.9%).
BayCom Corp is a U.S.-headquartered bank holding company operating through its wholly owned subsidiary Bay Commercial Bank. It primarily serves small and medium-sized enterprises and retail customers across Northern California, offering commercial lending, deposit products, personal banking services, and localized wealth management solutions.
TriSalus Life Sciences, Inc. is a clinical-stage biotechnology company focused on advancing immuno-oncology and interventional oncology solutions. It develops proprietary targeted drug delivery technologies designed to improve treatment efficacy for patients with liver, pancreatic and other hard-to-treat solid tumors, primarily operating in North American markets via partnerships with clinical care and research institutions.
BCML vs TLSI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $25.9M | $13.2M |
| Net Profit | $6.9M | $-9.8M |
| Gross Margin | — | 86.7% |
| Operating Margin | 36.6% | -24.8% |
| Net Margin | 26.5% | -73.9% |
| Revenue YoY | 9.4% | 59.8% |
| Net Profit YoY | 12.1% | 3.5% |
| EPS (diluted) | $0.63 | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $25.9M | $13.2M | ||
| Q3 25 | $25.7M | $11.6M | ||
| Q2 25 | $24.7M | $11.2M | ||
| Q1 25 | $24.3M | $9.2M | ||
| Q4 24 | $23.7M | $8.3M | ||
| Q3 24 | $25.6M | $7.3M | ||
| Q2 24 | $23.8M | $7.4M | ||
| Q1 24 | $24.5M | $6.5M |
| Q4 25 | $6.9M | $-9.8M | ||
| Q3 25 | $5.0M | $-10.8M | ||
| Q2 25 | $6.4M | $-8.3M | ||
| Q1 25 | $5.7M | $-10.4M | ||
| Q4 24 | $6.1M | $-10.1M | ||
| Q3 24 | $6.0M | $-2.4M | ||
| Q2 24 | $5.6M | $-4.3M | ||
| Q1 24 | $5.9M | $-13.2M |
| Q4 25 | — | 86.7% | ||
| Q3 25 | — | 83.5% | ||
| Q2 25 | — | 83.9% | ||
| Q1 25 | — | 83.7% | ||
| Q4 24 | — | 85.3% | ||
| Q3 24 | — | 86.3% | ||
| Q2 24 | — | 87.6% | ||
| Q1 24 | — | 85.0% |
| Q4 25 | 36.6% | -24.8% | ||
| Q3 25 | 26.3% | -77.9% | ||
| Q2 25 | 35.3% | -65.4% | ||
| Q1 25 | 31.6% | -79.9% | ||
| Q4 24 | 34.2% | -91.8% | ||
| Q3 24 | 32.4% | -118.9% | ||
| Q2 24 | 31.9% | -111.0% | ||
| Q1 24 | 33.3% | -180.8% |
| Q4 25 | 26.5% | -73.9% | ||
| Q3 25 | 19.5% | -93.5% | ||
| Q2 25 | 25.8% | -73.9% | ||
| Q1 25 | 23.4% | -113.2% | ||
| Q4 24 | 25.9% | -122.4% | ||
| Q3 24 | 23.5% | -32.6% | ||
| Q2 24 | 23.6% | -58.8% | ||
| Q1 24 | 24.0% | -204.5% |
| Q4 25 | $0.63 | $-0.22 | ||
| Q3 25 | $0.46 | $-0.96 | ||
| Q2 25 | $0.58 | $-0.27 | ||
| Q1 25 | $0.51 | $-0.39 | ||
| Q4 24 | $0.55 | $-0.38 | ||
| Q3 24 | $0.54 | $-0.12 | ||
| Q2 24 | $0.50 | $-0.21 | ||
| Q1 24 | $0.51 | $-0.60 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $20.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $338.6M | $-33.9M |
| Total Assets | $2.6B | $35.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $20.4M | ||
| Q3 25 | — | $22.7M | ||
| Q2 25 | — | $26.5M | ||
| Q1 25 | — | $13.0M | ||
| Q4 24 | — | $8.5M | ||
| Q3 24 | — | $11.3M | ||
| Q2 24 | — | $16.5M | ||
| Q1 24 | — | $4.0M |
| Q4 25 | $338.6M | $-33.9M | ||
| Q3 25 | $334.3M | $-26.7M | ||
| Q2 25 | $330.6M | $-19.4M | ||
| Q1 25 | $329.3M | $-34.4M | ||
| Q4 24 | $324.4M | $-25.9M | ||
| Q3 24 | $321.7M | $-20.4M | ||
| Q2 24 | $315.3M | $-25.3M | ||
| Q1 24 | $314.2M | $-36.0M |
| Q4 25 | $2.6B | $35.3M | ||
| Q3 25 | $2.6B | $36.5M | ||
| Q2 25 | $2.6B | $41.3M | ||
| Q1 25 | $2.6B | $28.6M | ||
| Q4 24 | $2.7B | $24.0M | ||
| Q3 24 | $2.6B | $27.5M | ||
| Q2 24 | $2.6B | $32.4M | ||
| Q1 24 | $2.6B | $17.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $31.8M | $-2.5M |
| Free Cash FlowOCF − Capex | $30.1M | $-2.5M |
| FCF MarginFCF / Revenue | 116.2% | -19.1% |
| Capex IntensityCapex / Revenue | 6.7% | 0.3% |
| Cash ConversionOCF / Net Profit | 4.64× | — |
| TTM Free Cash FlowTrailing 4 quarters | $51.1M | $-19.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $31.8M | $-2.5M | ||
| Q3 25 | $7.3M | $-3.7M | ||
| Q2 25 | $6.4M | $-7.3M | ||
| Q1 25 | $9.3M | $-4.5M | ||
| Q4 24 | $30.4M | $-5.7M | ||
| Q3 24 | $9.6M | $-10.8M | ||
| Q2 24 | $7.7M | $-13.4M | ||
| Q1 24 | $5.1M | $-10.9M |
| Q4 25 | $30.1M | $-2.5M | ||
| Q3 25 | $6.2M | $-3.9M | ||
| Q2 25 | $5.6M | $-7.4M | ||
| Q1 25 | $9.1M | $-5.3M | ||
| Q4 24 | $28.7M | $-5.8M | ||
| Q3 24 | $9.4M | $-11.0M | ||
| Q2 24 | $7.4M | $-13.5M | ||
| Q1 24 | $3.9M | $-10.9M |
| Q4 25 | 116.2% | -19.1% | ||
| Q3 25 | 24.3% | -33.9% | ||
| Q2 25 | 22.8% | -66.1% | ||
| Q1 25 | 37.6% | -57.3% | ||
| Q4 24 | 121.1% | -69.7% | ||
| Q3 24 | 36.6% | -149.9% | ||
| Q2 24 | 31.2% | -183.1% | ||
| Q1 24 | 16.1% | -169.3% |
| Q4 25 | 6.7% | 0.3% | ||
| Q3 25 | 4.3% | 1.9% | ||
| Q2 25 | 3.0% | 0.8% | ||
| Q1 25 | 0.6% | 8.2% | ||
| Q4 24 | 7.2% | 0.6% | ||
| Q3 24 | 1.0% | 2.3% | ||
| Q2 24 | 1.0% | 0.8% | ||
| Q1 24 | 4.7% | 1.0% |
| Q4 25 | 4.64× | — | ||
| Q3 25 | 1.47× | — | ||
| Q2 25 | 1.00× | — | ||
| Q1 25 | 1.63× | — | ||
| Q4 24 | 4.96× | — | ||
| Q3 24 | 1.60× | — | ||
| Q2 24 | 1.37× | — | ||
| Q1 24 | 0.86× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.